Limb, genital, CNS, and facial malformations result from gene/environment-induced cholesterol deficiency: Further evidence for a link to sonic hedgehog

American Journal of Medical Genetics

Volumn 73, Issue 1, 1997, Pages 24-31

  Lanoue, Louise ^a   Dehart, Deborah B ^a   Hinsdale, Myron E ^b   Maeda, Nobuyo ^b   Tint, G Stephen ^c   Sulik, Kathleen K ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cholesterol synthesis inhibitor; Mutant mice; Smith Lemli Opitz syndrome

Indexed keywords

CHOLESTEROL; GENE PRODUCT; SONIC HEDGEHOG PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN AQUEDUCT STENOSIS; CHOLESTEROL SYNTHESIS; EMBRYO DEVELOPMENT; FACE MALFORMATION; GENITAL MALFORMATION; HOLOPROSENCEPHALY; HYPOCHOLESTEROLEMIA; LIMB MALFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME;

ANIMALS; APOLIPOPROTEINS B; CENTRAL NERVOUS SYSTEM; CHOLESTEROL; FACE; FEMALE; GENITALIA; HEDGEHOG PROTEINS; LIMB DEFORMITIES, CONGENITAL; MALE; MICE; MICE, INBRED ICR; PIPERAZINES; PREGNANCY; PROTEINS; RATS; RATS, WISTAR; TRANS-ACTIVATORS;

ANIMALIA; ERINACEIDAE;

EID: 0030716476     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19971128)73:1<24::AID-AJMG6>3.0.CO;2-P     Document Type: Article

References (46)

1. Allain CA, Poon LS, Chan CSG, Richmond W, Fu PC (1974): Enzymatic determination of total serum cholesterol. Clin Chem 29:470.
2. Alley TL, Gray BA, Lee S-H, Scherer S, Tsui L-C, Tint GS, Williams CA, Zori R, Wallace MR (1995): Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q32.1 in a Smith-Lemli-Opitz syndrome patient. Am J Hum Genet 56:1411-1416.
3. Barbu V, Roux C, Dupuis R, Gardette J, Maziere JC (1984): Teratogenic effect of AY 9944 in rats: Importance of the day of administration and maternal plasma cholesterol level (41842). Proc Soc Exp Biol Med 176: 54-59.
4. Barbu V, Roux C, Lambert D, Dupuis R, Gardette J, Maziere JC, Maziere C, Elefant E, Polonovski J (1988): Cholesterol prevents the teratogenic action of AY9944: Importance of the timing of cholesterol supplementation to rats. J Nutr 118:774-779.
5. Belloni E, Muenke M, Roessler E, Traverso G, Siegel-Bartelt J, Frumkin A, Mitchell HF, Donis-Keller H, Helms C, Hing AV, Heng HHQ, Koop B, Martindale D, Rommens JM, Tsui LC, Scherer SW (1996): Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 14:363-356.
6. Buc-Caron MH, Condamine H, Kerjaschki D (1987): Rat Heymann Nephritis antigen is closely related to Brushin, a glycoprotein present in early mouse embryo epithelia. Ann Inst Pasteur/Immunol 138:707-722.
7. Chasalow FI, Blethen SL, Taysi K (1985): Possible abnormalities of steroid secretion in children with Smith-Lemli Opitz syndrome and their parents. Steroids 46:827-843.
8. Chiang C, Litingung Y, Lee E, Young KE, Corden JE, Westphal H, Beachy, PA (1996): Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383:407-413.
9. Cohen MM Jr, Sulik KK (1992): Perspectives on holoprosencephaly. Part II. Central nervous system, craniofacial anatomy, syndrome commentary, diagnostic approach, and experimental studies. J Craniofac Genet Dev Biol 12:196-244.
10. Curry CJ, Carey JC, Holland JS, Chopra D, Fineman R, Golabi M, Sherman S, Pagon RA, Allanson J, Shulman S, Barr M, McGravey V, Dabiri C, Schimke N, Ives E, Ball BD (1987): Smith-Lemli-Opitz syndrome type II: Multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. Am J Med Genet 26:45-57.
11. Dehart DB, Lanoue L, Tint GS, Sulik KK (1995): Altered cholesterol biosynthesis in rats: A model for Smith-Lemli-Opitz syndrome. Teratology 51(3):165.
12. Dehart DB, Lanoue L, Tint GS, Sulik KK (1996): Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome. Am J Med Genet 68:328-337.
13. Denno KM, Sadler TW (1995): Disruption of Sonic Hedgehog causes neural tube abnormalities. Teratology 51: 163A.
14. Donnai D, Young ID, Owen WG, Clark SA, Miller PFW, Knox WF (1986): The lethal multiple congenital anomaly syndrome of polydactyly, sex reversal, renal hypoplasia and unilobular lungs. J Med Genet 23:64-71.
15. Echelard Y, Epstein DJ, St-Jacques B, Shen L, Mohler J, McMahon JA, McMahon AP (1993): Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell 75:1417-1430.
16. Farese RV Jr, Ruland SL, Flynn LM, Stokowski RP, Young SG (1995): Knockout of the mouse apolipoprotein B gene result in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc Natl Acad Sci USA 92:1774-1778.
17. Gorlin RJ, Cohen MM Jr, Levin LS (1990): "Syndromes of the Head and Neck." New York: Oxford University Press, third edition, pp 890-895.
18. Hogan B, Costantini F, Lacy E (1996): "Manipulating the Mouse Embryo." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, second edition, pp 299-300.
19. Homanics GE, Maeda N, Traber MG, Kayden HJ, Dehart DB, Sulik KK (1995): Exencephaly and hydrocephaly in mice with targeted modification of the apolipoprotein B (Apob) gene. Teratology 51:1-10.
20. Homanics GE, Smith TJ, Zhang SH, Lee D, Young SG, Maeda N (1993): Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc Natl Acad Sci USA 90:2389-2393.
21. Johnson RL, Laufer E, Riddle RD, Tabin C (1994): Ectopic expression of sonic hedgehog alters dorsal-ventral patterning of somites. Cell 79: 1165-1173.
22. Kelley RI, Roessler E, Hennekam RCM, Feldman GL, Kosaki K, Jones MC, Palumbos JC, Muenke M (1996): Holoprosencephaly in RSH/Smith-Lemli-Opitz Syndrome: Does abnormal cholesterol metabolism affect the function of sonic hedgehog? Am J Med Genet 66:478-484.
23. Kotch LE and Sulik KK (1992): Patterns of ethanol-induced cell death in the developing nervous system of mice: Neural fold stages through the time of anterior neural tube closure. Int J Dev Neuroscience 10:273-279
24. Kounnas MZ, Haudenschild CC, Strickland DK, Argraves WS (1994): Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues. In Vivo 8:343-352.
25. Krauss S, Concordet JP, Ingham PW (1993): A functionally conserved homolog of the Drosophila segment polarity gene hedgehog is expressed in tissues with polarizing activity in zebrafish embryos. Cell 75:1431-1444.
26. Lanoue L, Dehart DB, Tint S, Maeda N, Sulik KK (1996): Gene-environment interactions in cholesterol deficiency-based malformations. Teratology 53:26A.
27. Marti E, Bumcrot DA, Takada R, McMahon AP (1995): Requirement of 19K form of Sonic hedgehog for induction of distinct ventral cell types in CNS explants. Nature 375:322-325.
28. Martin G (1996): Pass the butter... Science 274:203-204.
29. McKeever PA, Young ID (1990): Smith-Lemli-Opitz syndrome II: A disorder of the fetal adrenals? J Med Genet 27:465-466.
30. Porter JA, Young KE, Beachy, PA (1996): Cholesterol modification of hedgehog signaling proteins in animal development. Science 274:255-259.
31. Ramanathan R, Wilkemeyer MF, Mittal B, Perides G, Charness ME (1996): Alcohol inhibits cell-cell adhesion mediated by human L1. J Cell Biol 133:381-390.
32. Repetto M, Maziere JC, Citadelle D, Dupuis R, Meier M, Biade S, Quiec D, Roux C (1990): Teratogenic effect of the cholesterol synthesis inhibitor AY 9944 on rat embryos in vitro. Teratology 42:611-618.
33. Riddle R, Johnson RL, Laufer E, Tabin C (1993): Sonic hedgehog mediates the polarizing activity of the ZPA. Cell 75:1401-1416.
34. Roelink H, Porter JA, Chiang C, Tanabe Y, Chang DT, Beachy PA, Jessell TM (1995): Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog proteolysis. Cell 81:445-455.
35. Roelink H, Tanabe Y, Jessell TM (1996): Sonic hedgehog: A mediator of inductive signaling in the ventral neural tube. Sem Cell Dev Biol 7: 121-127.
36. Roux C, Aubry MM (1966): Action teratogène chez le rat d'un inhibiteur de la synthèse du cholesterol, le AY9944. C R Soc Biol 160:1353-1357.
37. Roux C, Dupuis R, Horvath C, Talbot JN (1980): Teratogenic effect of an inhibitor of cholesterol synthesis (AY 9944) in rats: Correlation with maternal cholesterolemia. J Nutr 110:2310-2312.
38. Roux C, Horvath C, Dupuis R (1979): Teratogenic action and embryo lethality of AY 9944. Prevention by a hypercholesterolcmia-provoking diet. Teratology 19:35-38.
39. Sowell ER, Jernigan TL, Mattson SN, Riley EP, Sobel DF, and Jones KL (1966): Abnormal development of the cerebellar vermis in children prenatally exposed to alcohol: Size reduction in lobules I-V. Alcohol Clin Exp Res 20:31-34
40. Sulik KK, Johnston MC (1982): Embryonic origin of holoprosencephaly: Interrelationship of the developing brain and face. Scan Elec Microsc 1:309-322.
41. Sulik KK, Lauder JM, Dehart DB (1984): Brain malformations in prenatal mice following acute maternal ethanol administration. Int J Dev Neuro 2:203-214.
42. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen T, Salen G (1994): Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330:107-113.
43. Tint GS, Seller M, Hughes-Benzie R, Batta AK, Shefer S, Genest D, Irons M, Elias E, Salen G (1995): Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of Smith-Lemli-Opitz syndrome. J Lipid Res 36:89-95.
44. Wei X, Sulik KK (1996): Pathogenesis of caudal dysgenesis/sirenomelia induced by ochratoxin A in chick embryos. Teratology 53:378-391.
45. Willnow TE, Hilpert J, Armstrong SA, Rohlmann A, Hammer RE, Burns DK, Herz J (1996): Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 93:8460-8464.
46. Xu G, Salen G, Shefer S, Ness GC, Chen TS, Zhao Z, Tint GS (1995): Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. J Clin Invest 95:76-81.